baber/WOPTO huggingface dataset:
Patent NZ-531333-A (NZ)
Title: Apparatus and method for optimizing the power transfer produced by a wave energy converter (WEC)
Inventor: BURNS JOSEPH R
IPC: F03B13/14
Filed: 2002-08-05
Abstract: A wave energy converter (WEC) is disclosed which includes a shell mounted about a piston which forms a combination, that when placed in a body of water, is responsive to waves in the body of water. This results in relative motion between the shells and the piston. A mechanical motion to electrical energy converter includes an electric generator which is responsive to the relative motion between the shell and the piston. Produced is an output of the electric generator of at least a voltage and current, which is a function of the relative motion between the shell and piston. A load is coupled to the output of the electric generator. The load has an impedance whose value is a function of the period of the waves, and the mass of the water in the shell. A controller is included for varying at least one of the effective resistance of the load and the impedance of the element coupling the load to the electric generator for optimizing power transfer, and maintaining resonance. A sensor is included for sensing selected points in the power generation loop, and producing signals applied to the controller for varying the load and the impedance of the coupling element. Further disclosed is a wave energy converter (WEC) and power generating system including a structure that has mechanical parts that move and drive an electric generator, when the structure is subjected to naturally recurring forces such as ocean waves. The output of the electric generator is a voltage, which is a function of the naturally recurring forces. The voltage at the output of the electric generator exhibits one of an inductance and capacitive resistance. A load coupled to the output of the electric generator has an impedance whose value is a function of the period of the naturally recurring forces, and of the mass being moved. A reactive component is coupled to the output of the electric generator, in series with the load. The reactive component is selected to be the other one of the inductive and capacitive reactance for enhancing resonance in the WEC or power generating system.
Patent NZ-532005-A (NZ)
Title: Hogging apparatus with screened tub with off-centred rotating reducing toothed assembly and rotating agitator
Inventor: SHARP RODNEY WARWICK
IPC: B27L11/00
Filed: 2004-03-29
Abstract: A tub 1, shown from above, has side wall 2 and screens with apertures 4, typically at the tub bottom 3. Typically the tub 1 rotates. A toothed reducing assembly 5 has its rotation axis off-centred from that of tub 1. An agitator 10 with shaft 12 having blades is rotated by motor 11 about an axis which is not co-axial with that of the tub 1.
Patent NZ-534638-A (NZ)
Title: Intervertebral implant
Inventor: MATHIEU CLAUDE
IPC: A61B17/80
Filed: 2002-02-19
Abstract: Disclosed is an intervertebral implant shaped as a three-dimensional body (10), comprising: a) a top side (1) and a bottom side (2) used for the positioning thereof against the end plates of two adjacent vertebral bodies; b) a left-hand surface (3) and a right-hand surface (4); c) a front surface (5) and a rear surface (6); d) a horizontal central plane (7) located between the top side (1) and the bottom side (2); e) a vertical central plane (8) located between the left-hand surface (3) and the right-hand surface (4); and f) a plurality of bore holes (9) penetrating the body (10), which receive longitudinal fixing elements (20) and the axes (19) of which intersect the horizontal central plane (7). At least one of said bore holes (9) is configured in such a way that a longitudinal fixing element (10) that is received therein can be connected in a rigid manner to the intervertebral implant. This procedure is carried out effectively by means of a screw thread or corresponding cone-shaped surfaces.
Patent NZ-546678-A (NZ)
Title: Tactile indicator for installation on walkway surface with second member extending out from first member
Inventor: HOMICKI DEAN
Filed: 2006-04-20
Abstract: The tactile indicator has a first member 12 and a second member 14 extending out from the first member parallel to the walkway surface.
Patent NZ-548656-A (NZ)
Title: A polymorph of R-(-)-modafinil, for use in treating sleep and other disorders
Inventor: BOURGHOL HICKEY MAGALI
IPC: A61K31/165
Filed: 2005-02-01
Abstract: Disclosed is a composition comprising R-(-)-modafinil Form V, which has powder XRD diffraction peaks at 6.61 degrees at least, and also at 10.39, 13.99, 16.49, 17.73, 20.87, and 22.31 degrees. Also disclosed is the use of Form V R-(-)-modafinil to treat excessive daytime sleepiness associated with narcolepsy, multiple sclerosis related fatigue, infertility, eating disorders, attention deficit hyperactivity disorder (ADHD), Parkinson's disease, incontinence, sleep apnea, or myopathies.
Patent NZ-549395-A (NZ)
Title: Pyrrolidine-3-4-dicarboxamide derivatives
Inventor: ANSELM LILLI
IPC: C07D417/12
Filed: 2005-03-17
Abstract: Disclosed are compounds of formula (I) wherein X is N or CR6; and wherein the rest of the substituents are disclosed within the specification; and pharmaceutically acceptable salts thereof. Also disclosed is a process of making compounds of formula (1), intermediates, and the use of compounds of formula (I) for the preparation of medicaments for the treatment of diseases associated with the coagulation factor Xa.
Patent NZ-550174-A (NZ)
Title: Combinations comprising a vasculostatic compound such as vatalanib and epothilones, and pharmaceutical uses thereof
Inventor: CHEN TIANLING
IPC: A61K33/243
Filed: 2002-07-18
Abstract: Disclosed herein is a combination which comprises (a) a vasculostatic compound which decreases the activity of VEGF and (b) an epothilone derivative of formula (I), wherein A represents O or NRN, wherein RN is hydrogen or lower alkyl, R is hydrogen or lower alkyl, and Z is O or a bond, in which the active ingredients (a) and (b) are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier; for simultaneous, separate or sequential use. (62) Divided Out of 530572
Patent NZ-551490-A (NZ)
Title: Single lumen adapter for automatic valve
Inventor: HANLON JAMES G
IPC: F16K24/04
Filed: 2006-11-22
Abstract: A valve system comprising: a valve connector (222) including a portion of a first passageway, the valve connector further including a suction port and an introduction port (232) that are spaced apart, the suction port and the introduction port establishing fluid communication between the portion of the first passageway and the suction port or the introduction port. At least one port of the valve connector has a collar (378), the collar having a plurality of flexible protrusions of the same diameter at an inner periphery of the collar. The collar is adapted to press fit with a medical device.
Patent NZ-552093-A (NZ)
Title: Processes for preparing gonadotropin releasing hormone receptor antagonists
Inventor: GONTCHAROV ALEXANDER V
IPC: A61K31/496
Filed: 2005-06-16
Abstract: Disclosed are methods of making Gonadotropin Releasing Hormone ("GnRH") (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists.
Patent NZ-552253-A (NZ)
Title: Lantern for emitting a warning signal in a circular manner
Inventor: KOLB KLAUS
IPC: F21V5/04
Filed: 2005-06-15
Abstract: Lamp for radiation of a warning signal in all directions around a lamp axis V V, with a base body fixable at a mounting location and at least one optical basic arrangement comprising an annular support element and an inner 16 and outer 2 drum optical system, wherein a number of lighting means 15 is arranged on the support element in annular distribution and the support element has a drum reflector 17 18, each of the lighting means 15 radiates light radially outwardly with respect to the lamp axis V V in a three-dimensional angular range which, around the lamp axis V V, covers an azimuth angle y substantially smaller than 3600 and, relative to the lamp axis V V, a polar angle 8 substantially greater than a desired polar angular range in which the warning signal is radiated about a mean polar direction u, light central light radiated by the lighting means 15 relative to the lamp axis V V in a central polar angular range containing the mean polar direction u passes through the inner 16 and outer 2 drum optical system without prior incidence on the drum reflector 17 18, the central light includes light inner central light radiated in a polar middle region containing the mean polar direction u and light outer central light radiated in two polar outside regions each adjoining the polar centre region at a respective side, light outside light radiated by the lighting means 15 outside the central polar angular range is initially reflected by the drum reflector 17 18 radially outwardly and only then passes through the inner 16 and outer 2 drum optical system and the inner central light does not intersect the outside light at least until entry into the inner drum optical system 16 and the outer central light intersects the outside light at the latest on issue from the inner drum optical system 16, the outer central light insofar as it has penetrated the inner drum optical system 16 in a region which was also penetrated by the outside light penetrates the outer drum optical system 2 in a first outer outside region which is penetrated only by this part of the outer central light and not also by the inner central light or by the outside light, the arrangement of the lighting means 15 and the drum reflector 17 18 on the support element, the arrangement of the support element and the drum optical system 16 2 and the construction of the drum reflector 17 18 and the drum optical system 16 2 are so adapted to one another that both the central light and the outside light after issue from the outer drum optical system are radiated in polar direction within the desired polar angular range /3 about the mean polar direction u.
Patent NZ-552299-A (NZ)
Title: Gaming machine with multiple master controllers
Inventor: SHELLEY SCOTT
Filed: 2005-07-05
Abstract: A gaming machine comprises a housing, at least one display associated with the housing and means to control game play. The means to control game play comprises at least two game controllers. The game controllers operate independently or in conjunction with each other allowing at least two games to be played on one gaming machine separately or concurrently.
Patent NZ-552625-A (NZ)
Title: Method and apparatus for forming cracks in concrete by impacting along the lines of an inset in the cast slab
Inventor: COCKERELL ALLAN DAVID
IPC: E01C23/12
Filed: 2005-07-04
Abstract: A method and apparatus (24) for forming at least one crack (11) in a concrete article (25) is disclosed. The concrete article (25), such as a floor slab, has at least one crack promoting insert (12) cast within it. The method comprises the steps of positioning a tool having a force applying member (26) on or above the insert (12) imbedded in the concrete article (25) then causing the tool to apply through the force applying member (26) a force to the concrete article (25). This will promote the formation of a crack (11) in the concrete article (25) along the insert (12).
Patent NZ-566210-A (NZ)
Title: Rotary hearth furnace that prevents the refractory material for falling under the effects of thermal expansion
Inventor: SUGITATSU HIROSHI
IPC: F27B9/18
Filed: 2006-10-10
Abstract: A rotary hearth furnace of a general-purpose type, which has a simple hearth structure which does not cause any damage to the hearth due to expansion of refectory material even after long-term operation is disclosed. A radial thermal expansion tolerance X defined by a formula (2) is set between an outer peripheral or inner peripheral corner refractory material and the refractory material or between the refractory materials when the requirement represented by formula (1) is satisfied: X + A < "(A2 + B2) ··(1) wherein A represents the width of an outer peripheral corner refractory material (7); and B represents the height of a support metal material (11) of the corner refractory material (7). X = ([X0=] distance between the outer end part of the outer peripheral support metal material (11) and the inner end part of the inner peripheral support metal material (12) at the operation temperature) - ([X1=] sum of the length at room temperature in a radial direction of a plurality of refractory materials (6) and corner refractory materials (7,8)) ··(2)
Patent NZ-567094-A (NZ)
Title: Solid orally administerable pharmaceutical dosage forms with rapid active principle release
Inventor: BENKE KLAUS
IPC: A61K9/16
Filed: 2006-09-21
Abstract: The disclosure relates to solid orally administrable pharmaceutical dosage forms comprising 5-chlorine-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophene carboxamide in amorphous form and/or as a thermodynamically metastable crystal modification, wherein the dosage form has a rapid release profile, and to methods for the production thereof, their use as medicaments, their use for the prophylaxis, secondary prophylaxis and/or treatment of diseases as well as to their use for producing a medicament for the prophylaxis, secondary prophylaxis and/or treatment of diseases. Particularly disclosed is a solid pharmaceutical dosage form which can be administered orally, comprises 5-chlorine-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophene carboxamide (I) and has rapid release, characterized in that it comprises active ingredient (I) in amorphous form or thermodynamically metastable crystal modification, wherein the active ingredient (I) is amorphized or converted into a thermodynamically metastable crystal modification by a dissolving method wherein acetic acid is employed as solvent, and polyvinylpyrrolidone is added, and the active ingredient (I) is present in a concentration of from 0.1 to 30% in the mixture resulting from the dissolving method; or wherein the active ingredient (I) is amorphized or converted into a thermodynamically metastable crystal modification by a melting method wherein polyethylene glycols or mixtures of polyethylene glycols are employed in the melting method, and the active ingredient (I) is present in a concentration of from 0.1 to 30% in the mixture resulting after the melting process; or wherein the active ingredient (I) is amorphized or converted into a thermodynamically metastable crystal modification by melt extrusion wherein hydroxypropylcellulose (HPC) or polyvinylpyrrolidone (PVP) is employed as polymer in the melt extrusion, the proportion of polymer in the melt extrudate is at least 40%, and the active ingredient (I) is present in the melt extrudate in a concentration of from 0.1 to 20%.
Patent NZ-567188-A (NZ)
Title: Stable pharmaceutical composition comprising a pyrimidine-sulfamide
Inventor: ADESUYI CHARLES TOKUNBO
IPC: A61K9/00
Filed: 2006-09-11
Abstract: Disclosed is a composition comprising propylsulfamic acid [5-(bromo-phenyl)-6-[2-(5-bromo-pyrimidin-2yloxy)-ethoxy]-pyrimidin-4-yl]-amide or pharmaceutically acceptable salts, solvates, hydrates or morphological forms thereof, lactose monohydrate with microcrystalline cellulose, sodium starch glycolate or a combination of sodium starch glycolate and polyvinylpyrrolidone, a surfactant, consisting of a polysorbate and magnesium stearate. Also disclosed is the use of said composition in the treatment of hypertension.
Patent NZ-577397-A (NZ)
Title: Factor ix moiety-polymer conjugates having a releasable linkage
Inventor: BOSSARD MARY J
IPC: A61P7/00
Filed: 2007-12-27
Abstract: A Factor IX moiety-polymer conjugate having a releasable linkage. The linkage is derived from 9H-flouroene and the polymer is a water-soluble polymer, in particular polyethylene glycol (PEG). The conjugate can be used for treating a bleeding disorder.
Patent NZ-577638-A (NZ)
Title: Tricyclic fused compounds useful as protein kinase inhibitors
Inventor: CHARRIER JEAN DAMIEN
IPC: C07D475/12
Filed: 2007-12-14
Abstract: The disclosure relates to dihydro-imidazol derivatives of formula (I), wherein the variables are as defined in the specification; pharmaceutically acceptable compositions comprising these compounds and methods of using the compositions in the treatment of various disorders in non-human animals; and processes for preparing these compounds. These compounds are useful as inhibitors of protein kinases and are suitable for treating a proliferative disorder (such as melanoma, myeloma, leukemia, lymphoma, neuroblastoma, or a cancer selected from colon, breast, gastric, ovarian, cervical, lung, central nervous system (CNS), renal, prostate, bladder, or pancreatic), a neurodegenerative disorder, an autoimmune disorder, an inflammatory disorder, or an immunologically mediated disorder in a non-human animal.
Patent NZ-577654-A (NZ)
Title: Cationic surfactant systems comprising microfibrous cellulose
Inventor: SWAZEY JOHN M
IPC: C11D1/38
Filed: 2007-12-12
Abstract: Disclosed is a composition which comprises microfibrous cellulose (at a concentration of about 0.05% to about 0.09% w/w), a cationic surfactant such as benzylalkonium chloride (at about 0.05% to about 50% w/w active surfactant), and a suspended particulate such as beads, or alternatively any substance which may have air bubbles suspended therein. The composition can be prepared by simply mixing the individual components, and it may be utilised as an anti-bacterial hard surface cleaner
Patent NZ-583090-A (NZ)
Title: Improvements in or relating to organic compounds
Inventor: BELL GORDON ALASTAIR
IPC: A01N25/02
Filed: 2008-08-12
Abstract: Disclosed is a composition comprising: 1) A solvent represented by general formula CH3CH(OH)C(=O)NR1R2 and 2) An agrochemical of Trinexepac ethyl, Mandipropamid, Abamectin or Emamectin. Also disclosed is the use of the above composition for controlling a plant pest.
Patent NZ-588955-A (NZ)
Title: Novel amino acid derivatives including a disulfide (disulphide), method for preparing same, and therapeutic use thereof
Inventor: FOURNIE-ZALUSKI MARIE-CLAUDE
IPC: C07C323/65
Filed: 2009-05-13
Abstract: The disclosure relates to amino acid derivative compounds of the formula (I) R1NH-CH(R2)-CH2-S- S-CH2-C(R3)(R4)-CONH-C(R5)(R6)-COOR7 (I) in which R1 is a (acyloxy)alkyl carbamate -C(O)-O-C(R8)(R9)-OC(O)-R10 group; R2 is a hydrocarbon chain, a methylene radical substituted by a heterocycle; R4 is a hydrogen atom and R3 is a phenyl or benzyl radical, a heteroaryl, a methylene group substituted by a heterocycle or R3 and R4 form together a saturated cycle; R5 and R6 are hydrogen, a hydrocarbon chain, a phenyl or benzyl radical or R5 and R6 form together a saturated cycle; R7 is hydrogen, a phenyl or benzyl radical, a group of the formula CR12(R13)C(O)OR14 or OCR12(R13)OC(O)R14 or OCR12(R13)OC(O)OR14. The disclosure also relates to the combined use of at least one cannabinoid derivative and/or morphine or one derivative thereof and/or Gaba derivatives for enhancing the analgesic and anti-depressive effect of these amino acid derivatives of formula (I).
Patent NZ-589062-A (NZ)
Title: Tricyclic nitrogen containing compounds and their use as antibacterials
Inventor: ALEMPARTE-GALLARDO CARLOS
IPC: A61K31/4745
Filed: 2009-05-20
Abstract: Disclosed are triazaacenaphthylene compounds represented by general formula (I). Examples of the compounds of formula (I) include: (1R)-1-[(4-{ [(5-chloro-6-methyl-3-pyridinyl)methyl]amino} -1-piperidinyl)methyl]-1,2-dihydro-4H,9H-imidazo[1,2,3-ij]-1,8-naphthyridine-4,9-dione; (2R)-2-[(4-{ [(5-chloro-6-methyl-3-pyridinyl)methyl]amino} -1-piperidinyl)methyl]-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione; (1R)-1-{ [4-({ [6-(trifluoromethyl)-3-pyridinyl]methyl} amino)-1-piperidinyl]methyl} -1,2-dihydro-4H,9H-imidazo[1,2,3-ij]-1,8-naphthyridine-4,9-dione; The compound are used to treat tuberculosis.
Patent NZ-591564-A (NZ)
Title: Combustion nailer with control system to disable main tool function and run fan until lower temperature reached or time-out occurs
Inventor: MOELLER LARRY M
IPC: B25C1/08
Filed: 2006-05-19
Abstract: The combustion nailer has a control system which disables a main tool function such as fuel injector output when predetermined temperature of the power source and then runs a fan until either the temperature drops to a predetermined lower temperature, or a time-out occurs.
Patent NZ-595087-A (NZ)
Title: Novel amino azaheterocyclic carboxamides
Inventor: SUTTON AMANDA E
IPC: C07D239/94
Filed: 2010-02-04
Abstract: The invention provides novel substituted amino azaheterocyclic carboxamide compounds according to Formula (I) wherein X is N or C-R3, Y is NH, O or absent, R1 is a side group comprised of substituted alkylene, aryl, cycloalkyl, secondary amine, amide, sulfonamide etc functionalities and the other substituents are as given in the description. their manufacture and use for the treatment of hyperproliferative diseases, such as cancer. Keywords Quinoline, Quinazoline some chemical names 4-{ 3-[3-(3-Methoxy- propyl)-ureido]- benzylamino} -quinazoline-8-carboxylic acid amide, 4-[3-(4-Bromo-benzoylamino)-benzylamino]-quinazoline-8-carboxylic acid amide
Patent NZ-598653-A (NZ)
Title: Highly concentrated pharmaceutical formulations comprising anti-cd20 antibody
Inventor: STAUCH OLIVER BORIS
IPC: A61K9/00
Filed: 2010-09-10
Abstract: NZ 598653 Disclosed is a highly concentrated, stable pharmaceutical formulation for subcutaneous administration of a pharmaceutically active anti-CD20 antibody comprising: about 50 to 350 mg/ml anti-CD20 antibody; about 1 to 100 mM of a buffering agent providing a pH of 5.5 ± 2.0; about 1 to 500 mM of a stabiliser or a mixture of two or more stabilisers; about 0.01 to 0.1 % of a nonionic surfactant; and about 1’000 to about 16’000 U/ml of a hyaluronidase enzyme.
Patent NZ-600028-A (NZ)
Title: Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis
Inventor: KLAVENESS JO
IPC: A61K9/02
Filed: 2008-12-12
Abstract: ABSTRACT - 600028 The disclosure relates to a solid pharmaceutical product comprising a photosensitiser which is 5-aminolevulinic acid ester (5-ALA ester) of general formula (I), or a pharmaceutically acceptable salt thereof: R22N-CH2COCH2-CH2CO-OR1 (I) wherein R1 represents a substituted or unsubstituted, straight-chained, branched or cyclic alkyl group; and each R2 independently represents a hydrogen atom; and at least one pharmaceutically acceptable carrier or excipient which is a hard fat or a mixture of hard fat and additives; wherein said pharmaceutical product is provided in the form of a suppository, wherein said product is adapted for insertion into the uterus, vagina or cervix and is suitable for the photodynamic treatment of cancer, an infection associated with cancer, or the treatment of a non-cancerous condition.
Patent NZ-601082-A (NZ)
Title: Anthelmintic Formulations and Treatments Comprising Separate Marcolactone and Levamisole Containing Formulations
Inventor: VICKERS MARK COLIN
IPC: A61K31/41
Filed: 2007-11-20
Abstract: 601082 Disclosed herein is a method of controlling parasites in ruminants and extending the time between treatment to minimise drench use, by treating the animal with at least (a) a long acting macrocylic lactone anthelmintic formulation A capable of providing a persistent anthelmintic activity of from 3-14 days so that it is capable of removing or killing incoming larvae for a sufficiently long period to allow the host to recognise incoming larvae as foreign and mount an immune response/self-treatment effect to reduce the effect of the parasite including reduce egg output and incoming larvae, and (b) treating the ruminant with a short acting levamisole anthelmintic formulation B to substantially eliminate the initial adult and immature parasite population present in the animal. More particularly wherein formulation A comprises ivermectin.